To further examine the impact of MBD2 expression on SLE disease activity, patients were categorized into inactive (SLEDAI ≤ 4) and active groups (SLEDAI > 4) according to the SLEDAI-2K. Here, MBD2 is linked to systemic lupus erythematosus.